Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 49,437 shares at $32.96 ($1.6M) on 2021-06-07, disclosed to the SEC on 2021-06-07.
Open-market sale of $1.6M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.92 | 9,824 | $314K | 19.8% |
| 2 | $31.92 | 9,824 | $314K | 19.8% |
| 3 | $30.80 | 3,544 | $109K | 6.9% |
| 4 | $30.80 | 3,544 | $109K | 6.9% |
| 5 | $31.28 | 2,068 | $65K | 4.1% |
| 6 | $31.28 | 2,068 |
| $65K |
| 4.1% |
| 7 | $30.74 | 1,058 | $33K | 2.1% |
| 8 | $32.25 | 749 | $24K | 1.5% |
| 9 | $32.96 | 8,379 | $276K | 17.4% |
| 10 | $32.96 | 8,379 | $276K | 17.4% |
| Total | $32.04 avg | 49,437 | $1.6M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |